Industrial Hemp Regulations Reform: Health Canada's 2026 Consultation and What Hemp Growers Should Say Before June 30

Executive Summary

Health Canada published a Notice of Intent on May 15, 2026 asking for feedback on potential amendments to the Industrial Hemp Regulations (IHR). The department wants to know which requirements impose unnecessary burden, whether the 0.3% THC definition should change, and how the List of Approved Cultivars should be managed. The 45-day comment period closes on June 30, 2026. This is the most significant opening for hemp regulatory reform since the Cannabis Act came into force in 2018, and submissions sent now will shape the rules your business operates under for the next decade. This article explains what is proposed, who stands to benefit, what will likely stay controlled, and how to write a submission that actually gets read.

Introduction

If you grow, process, import, or export industrial hemp in Canada, you have probably said some version of this at least once: "Why am I licensed like a cannabis company when I am farming a crop with almost no THC in it?"

Health Canada has finally asked the industry to answer that question on the record.

On May 15, 2026, the department published a Notice of Intent in the Canada Gazette, Part I, announcing a consultation on potential amendments to the Industrial Hemp Regulations. The stated goal is a risk-based framework that rightsizes requirements for hemp, cuts administrative burden, and reduces cost for both regulated parties and the government, while keeping the controls that prevent illegal cannabis cultivation disguised as hemp.

The consultation runs for 45 calendar days and closes on June 30, 2026. That deadline matters. Health Canada has confirmed that any future regulatory proposal coming out of this review will be prepublished in the Canada Gazette, Part I, which means the comments submitted now will set the starting point for the draft regulations themselves.

At MFLRC, we have supported cannabis and hemp businesses through licensing, compliance systems, and Health Canada interactions for years. Here is our practical read on the consultation and what we believe hemp businesses should put in their submissions.

What Is the Notice of Intent on the Industrial Hemp Regulations?

Direct answer: The Notice of Intent is a formal announcement from Health Canada, published in the Canada Gazette, Part I on May 15, 2026, that the department is reviewing the Industrial Hemp Regulations and seeking public feedback on potential amendments. It is not a draft regulation. It is the step before one. Comments are open until June 30, 2026 and can be sent by email to cannabis.consultation@canada.ca.

The notice was issued under the Cannabis Act by the Controlled Substances and Cannabis Branch. It frames the review as part of the Government of Canada's broader commitment to reduce red tape, announced through the Treasury Board's red tape reduction initiative in December 2025.

Two things make this consultation different from routine guidance updates.

First, Health Canada openly acknowledges the core industry argument. The notice states that industrial hemp has a lower potential for public health harms and misuse, and fewer public safety concerns, compared to cannabis because of its very low THC levels. That is a meaningful admission from the regulator, and it signals genuine willingness to remove requirements rather than just simplify forms.

Second, the department is asking structural questions, including whether the requirement to hold a licence at all should be eliminated or reduced for certain activities, and whether the definition of industrial hemp itself should change. These are foundation-level questions, not housekeeping.

Health Canada is also sending a separate voluntary cost-benefit analysis questionnaire to current hemp licence holders. If you hold a licence, respond to both. The questionnaire data feeds directly into the Regulatory Impact Analysis Statement that will accompany any proposed regulation.

How Are Hemp Businesses Regulated Today?

Direct answer: Under the current IHR, industrial hemp is defined as a cannabis plant, or any part of one, with a THC concentration of 0.3% (weight by weight) or less in the flowering heads and leaves. Most commercial activities with hemp require a Health Canada licence, and import or export of seed or grain requires a separate permit for each shipment on top of the licence.

The licence trigger list is long. Under the IHR, a person must hold a licence to do any of the following:

Activity requiring an IHR licence	Typical business affected
Cultivate industrial hemp	Farmers and growers
Sell industrial hemp	Brokers, distributors, growers selling crop
Import seed or grain	Seed suppliers, food processors
Export seed or grain	Exporters, grain marketers
Possess seed or grain to clean it	Seed cleaning facilities
Obtain seed by preparing it	Seed conditioners
Possess grain to process it	Food and ingredient processors
Propagate industrial hemp (plant breeders)	Breeding and genetics programs

On top of licensing, three other layers shape day-to-day compliance:

THC testing. Holders of a licence authorizing cultivation for seed must test the flowering heads and leaves to confirm THC concentration. If a crop tests above 0.3%, it no longer meets the definition of industrial hemp and falls under the full Cannabis Act control framework.

The List of Approved Cultivars (LOAC). Licensed cultivators may only grow varieties approved for commercial cultivation on the List of Approved Cultivars. Plant breeders get a narrow exception for varieties named in their licence.

Parallel CFIA requirements. The Canadian Food Inspection Agency's frameworks for seed quality, plant health, and movement of plant material apply independently. Imported hemp seed shipments need a phytosanitary certificate, and pedigreed seed status carries its own treatment requirements. These obligations are not part of the IHR review and will remain regardless of what Health Canada changes.

One more boundary worth understanding: the Cannabis Regulations still capture certain hemp-adjacent activities. If you want to isolate or concentrate phytocannabinoids, including extracting CBD from hemp flowering heads, you need a cannabis processing licence. The Notice of Intent does not propose moving CBD extraction out of the cannabis framework.

What Changes Is Health Canada Considering?

Direct answer: Health Canada has not published draft amendments yet. The Notice of Intent identifies the areas under review: eliminating or reducing licence and permit requirements, cutting reporting obligations, streamlining or reforming the LOAC, reducing THC testing requirements, and potentially modifying the 0.3% THC definition of industrial hemp. The department has asked six specific consultation questions to guide input.

The notice points to the precedent of the 2025 streamlining amendments to the Cannabis Regulations as the model for this exercise. The table below maps the current requirements against the reform questions Health Canada has put on the table.

Current requirement	What Health Canada is asking
Licence required for cultivation, sale, import, export, cleaning, preparing, and processing of seed or grain	Should licence requirements be eliminated or reduced for some of these activities?
Separate import/export permit for every seed or grain shipment	Does the permit layer impose unnecessary burden on top of licensing?
Mandatory THC testing of flowering heads and leaves for cultivation-for-seed licences	Can testing requirements be reduced or removed without compromising control?
Only LOAC-listed cultivars may be grown commercially	How should LOAC management be streamlined?
Industrial hemp defined as 0.3% THC or less (w/w) in flowering heads and leaves	Should the definition of industrial hemp be modified, and how?
Periodic reporting of licensed activities to Health Canada	Which reporting obligations can be cut while meeting international reporting commitments?

The six consultation questions

Health Canada wants feedback structured around these questions, though it will accept input on anything:

Which IHR requirements impose unnecessary burden on cultivation, importing and exporting, THC testing, selling flowering heads, leaves, and branches, and reporting?
What are the most important control measures to keep industrial hemp distinguishable from cannabis and prevent illegal cultivation and diversion?
What specific changes would streamline the IHR, what would you eliminate or reduce, and why?
Would you modify the current definition of industrial hemp, and if so, how and why?
What changes would streamline LOAC management?
Are there public health or public safety harms related to reducing the regulatory burden?

Notice the design of question 2 and question 6. Health Canada is not just collecting complaints. It is asking industry to help define which controls must survive. Submissions that engage seriously with those two questions will carry more weight than submissions that only ask for less regulation.

Who Benefits If the Reforms Go Ahead?

Direct answer: Grain and fibre producers, seed cleaners, food processors, and exporters stand to gain the most, because their activities involve plant material with negligible THC and their licence and permit burden is hardest to justify on risk grounds. Businesses working with flowering heads, CBD extraction, or cannabinoid products will likely see less change, because those activities sit closer to the Cannabis Act's control rationale.

Based on the structure of the notice, here is our assessment of where relief is most plausible:

Most likely to see meaningful relief. Import and export permits layered on top of licences are an obvious candidate, since the notice singles them out and CFIA phytosanitary controls already address plant health risk at the border. Reporting obligations are another, as the notice explicitly targets administrative burden such as completing forms and reporting information.

Reasonable prospects. Licence elimination for low-risk handling activities such as seed cleaning, grain possession for processing, and possibly grain-only cultivation. The industry has long argued hemp should be treated as an agricultural commodity, and the notice quotes that position without rebutting it.

Likely to stay controlled. Some form of cultivar management will survive, because Health Canada names the variety control system as a key measure for preventing illegal cannabis cultivation disguised as hemp. International drug control reporting obligations also constrain how far Canada can go, and the notice flags them directly. CBD and phytocannabinoid extraction stays under the Cannabis Regulations.

The wildcard. The 0.3% THC definition. Some jurisdictions and industry groups advocate for 1.0% THC, which would dramatically reduce crop failure risk from hot tests. Health Canada asking the question openly is notable, but a definition change has trade implications, since major export markets define hemp at 0.3%. If you comment on this question, address the export angle. A submission that ignores it will look incomplete.

How to Submit Comments Before June 30, 2026

Direct answer: Email your submission to cannabis.consultation@canada.ca with the subject line "Notice of Intent - Consultation on potential amendments to the Industrial Hemp Regulations" before June 30, 2026. Licence holders should also complete the voluntary cost-benefit analysis questionnaire that Health Canada is distributing separately.

A strong submission is specific, costed, and evidence-based. Here is the approach we recommend to clients.

Step-by-step: building a submission that gets read

Inventory your regulatory touchpoints. List every licence, permit, test, report, and record the IHR requires of your operation in a typical year.
Cost each one. Staff hours, lab fees, courier and brokerage costs from permit delays, lost sales windows, crop destruction from hot tests. Real numbers move regulators; adjectives do not.
Map each burden to a consultation question. Structure your submission around Health Canada's six questions so analysts can slot your input directly into their review.
Identify the controls you support keeping. Answer questions 2 and 6 honestly. Credibility on controls buys influence on relief.
Propose the specific amendment. Do not just say the permit system is slow. Say the separate import/export permit should be replaced by a notification requirement, and explain why that maintains traceability.
State your operational profile. Acres grown, activities licensed, years in operation, markets served. Context tells Health Canada whose burden your numbers represent.
Send it before June 30, 2026 and keep a copy with proof of transmission in your regulatory correspondence file.

Hemp consultation readiness checklist

Read the full Notice of Intent in the Canada Gazette, Part I
Confirm which IHR licences and permits your business currently holds
Quantify annual compliance costs (licensing, testing, reporting, permits)
Document at least one concrete example where a requirement caused delay or loss
Draft answers to all six consultation questions, including the control questions
Review your position on the 0.3% THC definition, including export market impact
Complete the cost-benefit questionnaire if you are a licence holder
Submit by email before June 30, 2026 with the correct subject line
File your submission and prepare to engage at the Canada Gazette, Part I prepublication stage

Common Mistakes Hemp Businesses Make in Consultations

We see the same handful of errors every time a consultation window opens. Avoid these:

Waiting for the draft regulations. By the time a proposal is prepublished in the Canada Gazette, Part I, the policy architecture is largely set. The Notice of Intent stage is where structural ideas get adopted or dropped. Commenting later is commenting at the margins.

Submitting opinions without numbers. "The permit system is burdensome" is an opinion. "Permit processing added 11 days and $4,200 in demurrage to our last export shipment" is evidence. Regulators draft cost-benefit statements from evidence.

Ignoring the public safety questions. Submissions that demand deregulation without addressing diversion controls give Health Canada nothing to work with. The department has to defend any relief it grants. Help it build that defence.

Assuming CFIA requirements will disappear too. This review covers the IHR only. Phytosanitary certificates, seed pedigree rules, and plant health controls are CFIA territory and remain in place. Plan your post-reform compliance picture accordingly.

Forgetting the CBD boundary. If your business model involves extracting cannabinoids from hemp, you still need a processing licence under the Cannabis Regulations. Nothing in this notice changes that, and submissions premised on hemp-derived CBD deregulation are aiming at the wrong consultation.

Missing the questionnaire. Licence holders who skip the cost-benefit questionnaire give up a second, direct channel into the Regulatory Impact Analysis Statement.

Key Dates and What Comes Next

Date	Milestone
May 15, 2026	Notice of Intent published; consultation opens
May to June 2026	Cost-benefit questionnaire distributed to hemp licence holders
June 30, 2026	45-day public comment period closes
Following months	Health Canada reviews input and develops policy direction
Future date	Any proposed amendments prepublished in Canada Gazette, Part I for further comment
Future date	Final regulations published in Canada Gazette, Part II, with coming-into-force provisions

There is no guaranteed timeline from consultation to final regulation, and the notice commits only to reviewing input to inform next steps. The 2025 cannabis streamlining package took several years from first consultation to final publication. Businesses should plan operations under the current IHR until amendments are actually in force, while positioning now for the framework that is coming.

Frequently Asked Questions

Do I still need a licence to grow industrial hemp in Canada in 2026?

Yes. The Notice of Intent does not change any current requirement. Until amended regulations come into force, all existing IHR licences, permits, testing, and reporting obligations continue to apply. Operating without a licence today remains a contravention of the Cannabis Act.

What is the THC limit for industrial hemp in Canada?

Industrial hemp is defined in the IHR as a cannabis plant, or any part of one, with a THC concentration of 0.3% (weight by weight) or less in the flowering heads and leaves. Health Canada is asking whether this definition should change, but no change has been made.

When does the Health Canada hemp consultation close?

The comment period closes on June 30, 2026, which is 45 calendar days after the Notice of Intent was published on May 15, 2026.

How do I submit comments on the Industrial Hemp Regulations consultation?

Email your input to cannabis.consultation@canada.ca with the subject line "Notice of Intent - Consultation on potential amendments to the Industrial Hemp Regulations". Provide rationale and evidence wherever possible, including anticipated impacts on industry, public health, and public safety.

Will hemp-derived CBD be deregulated through this consultation?

No. Isolating or concentrating phytocannabinoids, including CBD extraction from hemp, requires a processing licence under the Cannabis Regulations, and this consultation covers the Industrial Hemp Regulations only.

Will the List of Approved Cultivars be eliminated?

Health Canada is asking how LOAC management should be streamlined, but the notice also identifies variety management as a key control for preventing illegal cannabis cultivation disguised as hemp. Reform of the list is plausible; outright elimination appears less likely.

Do CFIA requirements for hemp seed change under this review?

No. CFIA frameworks for seed quality, plant health, and phytosanitary certification operate independently of the IHR and are not part of this consultation.

What happens after the consultation closes?

Health Canada will review submissions and develop next steps. Any future regulatory proposal will be prepublished in the Canada Gazette, Part I, giving stakeholders another formal comment opportunity before final regulations are made.

How MFLRC Can Help

A consultation window this consequential deserves more than a hastily written email. MFLRC works with hemp and cannabis businesses at every stage of the regulatory lifecycle, and we can help you turn operational frustration into a submission Health Canada can act on.

Our regulatory affairs and licensing team drafts consultation submissions, manages licence applications and renewals, and supports import and export compliance under both the IHR and the Cannabis Regulations. If you are unsure how proposed reforms would interact with your current licence structure, we run gap assessments that map your activities against both the existing framework and the likely future one.

For licence holders, our quality assurance services keep SOPs, records, and THC testing programs inspection-ready while the rules evolve, and our audit services include mock inspections and compliance reviews tailored to hemp operations. Businesses straddling the hemp-cannabis boundary, such as CBD extractors, can draw on our experience across cannabis and controlled substances frameworks to keep both sides of the line compliant.

Need help preparing your submission before June 30 or planning for the new framework? Book a consultation with MFLRC for expert guidance tailored to your business.

Book a Consultation with MFLRC

Conclusion

Health Canada has opened the door to the most substantial rethink of hemp regulation since 2018, and it has done so with language the industry has waited years to hear: requirements should reflect actual risk, and industrial hemp is not cannabis in any way that matters for public health. What happens next depends heavily on the quality of the submissions the department receives before June 30, 2026.

Send evidence, not adjectives. Engage with the control questions, not just the relief questions. And get your comments in on time, because the businesses that show up at the Notice of Intent stage are the ones whose fingerprints end up on the final regulations.